Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global and United States Rapid Prostate Cancer Tests Market Report & Forecast 2024-2030

Global and United States Rapid Prostate Cancer Tests Market Report & Forecast 2024-2030

Industry: Medical Devices & Consumables

Published Date: 2024-11-26

Pages: 114 Pages

Report ld: 3385689

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Rapid Prostate Cancer Tests Market Size(US$)

CAGR 2024-2030

4.3%

Market Size,2030

USD 99

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 77 million

Market Forecast in 2030(Value)

US$ 99 million

CAGR

4.3%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Rapid Prostate Cancer Tests revenue was US$ 73 million in 2023 and is forecast to a readjusted size of US$ 99 million by 2030 with a CAGR of 4.3% during the review period (2024-2030).

In United States the Rapid Prostate Cancer Tests revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).

This report focuses on global and United States Rapid Prostate Cancer Tests market, also covers the segmentation data of other regions in regional level and county level.

Rapid prostate cancer tests are diagnostic tools designed to quickly detect the presence of prostate cancer in individuals, often with minimal discomfort or invasive procedures. These tests are typically based on the detection of specific biomarkers such as prostate-specific antigen (PSA) or other molecular markers associated with prostate cancer. The advantage of rapid tests lies in their ability to provide results in a short time frame, allowing for earlier detection and quicker decision-making regarding further diagnostic procedures or treatment. Recent advancements in point-of-care testing and liquid biopsy technologies have significantly improved the speed, accuracy, and convenience of these tests, making them a valuable tool in both clinical and at-home settings. However, they are not yet a substitute for more comprehensive diagnostic methods, such as biopsy or imaging, and their use is often recommended as part of an overall screening strategy.

The global key players of Rapid Prostate Cancer Tests include Alfa Scientific Designs, BIOMERICA, Boson Biotech, MH medical, NanoEntek, PRIMA Lab, Shenzhen kangshengbao Biotechnology, Teco Diagnostics, etc. The global five biggest players hold a share of % in 2023.

Rapid Prostate Cancer Tests market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Rapid Prostate Cancer Tests market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.

For United States market, this report focuses on the Rapid Prostate Cancer Tests market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.

MARKET SEGMENTATION

By Company

Alfa Scientific Designs
BIOMERICA
Boson Biotech
MH medical
NanoEntek
PRIMA Lab
Shenzhen kangshengbao Biotechnology
Teco Diagnostics

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Serum
Whole Blood
Other

Segment by Application

Hospital
Laboratory

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces Rapid Prostate Cancer Tests definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Detailed analysis of Rapid Prostate Cancer Tests companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Revenue and volume of Rapid Prostate Cancer Tests in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.

Chapter 8: China by Type, and by Application, sales, and revenue for each segment.

Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rapid Prostate Cancer Tests sales, revenue, gross margin, and recent development, etc.

Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.

Chapter 12: research findings and conclusion

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Rapid Prostate Cancer Tests Product Introduction

1.2 Global Rapid Prostate Cancer Tests Outlook 2019 VS 2023 VS 2030

1.2.1 Global Rapid Prostate Cancer Tests Sales in US$ Million for the Year 2019-2030

1.2.2 Global Rapid Prostate Cancer Tests Sales in Volume for the Year 2019-2030

1.3 United States Rapid Prostate Cancer Tests Outlook 2019 VS 2023 VS 2030

1.3.1 United States Rapid Prostate Cancer Tests Sales in US$ Million for the Year 2019-2030

1.3.2 United States Rapid Prostate Cancer Tests Sales in Volume for the Year 2019-2030

1.4 Rapid Prostate Cancer Tests Market Size, United States VS Global, 2019 VS 2023 VS 2030

1.4.1 The Market Share of United States Rapid Prostate Cancer Tests in Global, 2019 VS 2023 VS 2030

1.4.2 The Growth Rate of Rapid Prostate Cancer Tests Market Size, United States VS Global, 2019 VS 2023 VS 2030

1.5 Rapid Prostate Cancer Tests Market Dynamics

1.5.1 Rapid Prostate Cancer Tests Industry Trends

1.5.2 Rapid Prostate Cancer Tests Market Drivers

1.5.3 Rapid Prostate Cancer Tests Market Challenges

1.5.4 Rapid Prostate Cancer Tests Market Restraints

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Rapid Prostate Cancer Tests by Type

2.1 Rapid Prostate Cancer Tests Market by Type

2.1.1 Serum

2.1.2 Whole Blood

2.1.3 Other

2.2 Global Rapid Prostate Cancer Tests Market Size by Type

2.2.1 Global Rapid Prostate Cancer Tests Sales in Value, by Type (2019, 2023 & 2030)

2.2.2 Global Rapid Prostate Cancer Tests Sales in Volume, by Type (2019, 2023 & 2030)

2.2.3 Global Rapid Prostate Cancer Tests Average Selling Price (ASP) by Type (2019, 2023 & 2030)

2.3 United States Rapid Prostate Cancer Tests Market Size by Type

2.3.1 United States Rapid Prostate Cancer Tests Sales in Value, by Type (2019, 2023 & 2030)

2.3.2 United States Rapid Prostate Cancer Tests Sales in Volume, by Type (2019, 2023 & 2030)

2.3.3 United States Rapid Prostate Cancer Tests Average Selling Price (ASP) by Type (2019, 2023 & 2030)

3 Rapid Prostate Cancer Tests by Application

3.1 Rapid Prostate Cancer Tests Market by Application

3.1.1 Hospital

3.1.2 Laboratory

3.2 Global Rapid Prostate Cancer Tests Market Size by Application

3.2.1 Global Rapid Prostate Cancer Tests Sales in Value, by Application (2019, 2023 & 2030)

3.2.2 Global Rapid Prostate Cancer Tests Sales in Volume, by Application (2019, 2023 & 2030)

3.2.3 Global Rapid Prostate Cancer Tests Average Selling Price (ASP) by Application (2019, 2023 & 2030)

3.3 United States Rapid Prostate Cancer Tests Market Size by Application

3.3.1 United States Rapid Prostate Cancer Tests Sales in Value, by Application (2019, 2023 & 2030)

3.3.2 United States Rapid Prostate Cancer Tests Sales in Volume, by Application (2019, 2023 & 2030)

3.3.3 United States Rapid Prostate Cancer Tests Average Selling Price (ASP) by Application (2019, 2023 & 2030)

4 Global Rapid Prostate Cancer Tests Competitor Landscape by Company

4.1 Global Rapid Prostate Cancer Tests Market Size by Company

4.1.1 Global Key Manufacturers of Rapid Prostate Cancer Tests, Ranked by Revenue (2023)

4.1.2 Global Rapid Prostate Cancer Tests Revenue by Manufacturer (2019-2024)

4.1.3 Global Rapid Prostate Cancer Tests Sales by Manufacturer (2019-2024)

4.1.4 Global Rapid Prostate Cancer Tests Price by Manufacturer (2019-2024)

4.2 Global Rapid Prostate Cancer Tests Concentration Ratio (CR)

4.2.1 Rapid Prostate Cancer Tests Market Concentration Ratio (CR) (2019-2024)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Rapid Prostate Cancer Tests in 2023

4.2.3 Global Rapid Prostate Cancer Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Manufacturers of Rapid Prostate Cancer Tests, Manufacturing Base Distribution and Headquarters

4.4 Global Key Manufacturers of Rapid Prostate Cancer Tests, Product Offered and Application

4.5 Global Key Manufacturers of Rapid Prostate Cancer Tests, Date of Enter into This Industry

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.7 United States Rapid Prostate Cancer Tests Market Size by Company

4.7.1 Key Players of Rapid Prostate Cancer Tests in United States, Ranked by Revenue (2023)

4.7.2 United States Rapid Prostate Cancer Tests Revenue by Players (2019-2024)

4.7.3 United States Rapid Prostate Cancer Tests Sales by Players (2019-2024)

5 Global Rapid Prostate Cancer Tests Market Size by Region

5.1 Global Rapid Prostate Cancer Tests Market Size by Region: 2019 VS 2023 VS 2030

5.2 Global Rapid Prostate Cancer Tests Market Size in Volume by Region (2019-2030)

5.2.1 Global Rapid Prostate Cancer Tests Sales in Volume by Region: 2019-2024

5.2.2 Global Rapid Prostate Cancer Tests Sales in Volume Forecast by Region (2025-2030)

5.3 Global Rapid Prostate Cancer Tests Market Size in Value by Region (2019-2030)

5.3.1 Global Rapid Prostate Cancer Tests Sales in Value by Region: 2019-2024

5.3.2 Global Rapid Prostate Cancer Tests Sales in Value by Region: 2025-2030

6 Americas

6.1 Americas Rapid Prostate Cancer Tests Market Size YoY Growth 2019-2030

6.2 Americas Rapid Prostate Cancer Tests Sales in Volume, by Type (2019, 2023 & 2030)

6.3 Americas Rapid Prostate Cancer Tests Sales in Volume, by Application (2019, 2023 & 2030)

6.4 Americas Rapid Prostate Cancer Tests Market Facts & Figures by Country (2019, 2023 & 2030)

6.4.1 Americas Rapid Prostate Cancer Tests Sales in Value by Country (2019, 2023 & 2030)

6.4.2 Americas Rapid Prostate Cancer Tests Sales in Volume by Country (2019, 2023 & 2030)

6.4.3 United States

6.4.4 Canada

6.4.5 Mexico

6.4.6 Brazil

7 EMEA

7.1 EMEA Rapid Prostate Cancer Tests Market Size YoY Growth 2019-2030

7.2 EMEA Rapid Prostate Cancer Tests Sales in Volume, by Type (2019, 2023 & 2030)

7.3 EMEA Rapid Prostate Cancer Tests Sales in Volume, by Application (2019, 2023 & 2030)

7.4 EMEA Rapid Prostate Cancer Tests Market Facts & Figures by Country (2019, 2023 & 2030)

7.4.1 EMEA Rapid Prostate Cancer Tests Sales in Value by Country (2019, 2023 & 2030)

7.4.2 EMEA Rapid Prostate Cancer Tests Sales in Volume by Country (2019, 2023 & 2030)

7.4.3 Europe

7.4.4 Middle East

7.4.5 Africa

8 China

8.1 China Rapid Prostate Cancer Tests Market Size YoY Growth 2019-2030

8.2 China Rapid Prostate Cancer Tests Sales in Volume, by Type (2019, 2023 & 2030)

8.3 China Rapid Prostate Cancer Tests Sales in Volume, by Application (2019, 2023 & 2030)

9 APAC

9.1 APAC Rapid Prostate Cancer Tests Market Size YoY Growth 2019-2030

9.2 APAC Rapid Prostate Cancer Tests Sales in Volume, by Type (2019, 2023 & 2030)

9.3 APAC Rapid Prostate Cancer Tests Sales in Volume, by Application (2019, 2023 & 2030)

9.4 APAC Rapid Prostate Cancer Tests Market Facts & Figures by Country (2019, 2023 & 2030)

9.4.1 APAC Rapid Prostate Cancer Tests Sales in Value by Country (2019, 2023 & 2030)

9.4.2 APAC Rapid Prostate Cancer Tests Sales in Volume by Country (2019, 2023 & 2030)

9.4.3 Japan

9.4.4 South Korea

9.4.5 China Taiwan

9.4.6 Southeast Asia

9.4.7 India

10 Company Profiles

10.1 Alfa Scientific Designs

10.1.1 Alfa Scientific Designs Company Information

10.1.2 Alfa Scientific Designs Description and Business Overview

10.1.3 Alfa Scientific Designs Rapid Prostate Cancer Tests Sales, Revenue and Gross Margin (2019-2024)

10.1.4 Alfa Scientific Designs Rapid Prostate Cancer Tests Products Offered

10.1.5 Alfa Scientific Designs Recent Development

10.2 BIOMERICA

10.2.1 BIOMERICA Company Information

10.2.2 BIOMERICA Description and Business Overview

10.2.3 BIOMERICA Rapid Prostate Cancer Tests Sales, Revenue and Gross Margin (2019-2024)

10.2.4 BIOMERICA Rapid Prostate Cancer Tests Products Offered

10.2.5 BIOMERICA Recent Development

10.3 Boson Biotech

10.3.1 Boson Biotech Company Information

10.3.2 Boson Biotech Description and Business Overview

10.3.3 Boson Biotech Rapid Prostate Cancer Tests Sales, Revenue and Gross Margin (2019-2024)

10.3.4 Boson Biotech Rapid Prostate Cancer Tests Products Offered

10.3.5 Boson Biotech Recent Development

10.4 MH medical

10.4.1 MH medical Company Information

10.4.2 MH medical Description and Business Overview

10.4.3 MH medical Rapid Prostate Cancer Tests Sales, Revenue and Gross Margin (2019-2024)

10.4.4 MH medical Rapid Prostate Cancer Tests Products Offered

10.4.5 MH medical Recent Development

10.5 NanoEntek

10.5.1 NanoEntek Company Information

10.5.2 NanoEntek Description and Business Overview

10.5.3 NanoEntek Rapid Prostate Cancer Tests Sales, Revenue and Gross Margin (2019-2024)

10.5.4 NanoEntek Rapid Prostate Cancer Tests Products Offered

10.5.5 NanoEntek Recent Development

10.6 PRIMA Lab

10.6.1 PRIMA Lab Company Information

10.6.2 PRIMA Lab Description and Business Overview

10.6.3 PRIMA Lab Rapid Prostate Cancer Tests Sales, Revenue and Gross Margin (2019-2024)

10.6.4 PRIMA Lab Rapid Prostate Cancer Tests Products Offered

10.6.5 PRIMA Lab Recent Development

10.7 Shenzhen kangshengbao Biotechnology

10.7.1 Shenzhen kangshengbao Biotechnology Company Information

10.7.2 Shenzhen kangshengbao Biotechnology Description and Business Overview

10.7.3 Shenzhen kangshengbao Biotechnology Rapid Prostate Cancer Tests Sales, Revenue and Gross Margin (2019-2024)

10.7.4 Shenzhen kangshengbao Biotechnology Rapid Prostate Cancer Tests Products Offered

10.7.5 Shenzhen kangshengbao Biotechnology Recent Development

10.8 Teco Diagnostics

10.8.1 Teco Diagnostics Company Information

10.8.2 Teco Diagnostics Description and Business Overview

10.8.3 Teco Diagnostics Rapid Prostate Cancer Tests Sales, Revenue and Gross Margin (2019-2024)

10.8.4 Teco Diagnostics Rapid Prostate Cancer Tests Products Offered

10.8.5 Teco Diagnostics Recent Development

11 Industry Chain and Sales Channels Analysis

11.1 Rapid Prostate Cancer Tests Industry Chain Analysis

11.2 Rapid Prostate Cancer Tests Key Raw Materials

11.2.1 Key Raw Materials

11.2.2 Raw Materials Key Suppliers

11.3 Rapid Prostate Cancer Tests Production Mode & Process

11.4 Rapid Prostate Cancer Tests Sales and Marketing

11.4.1 Rapid Prostate Cancer Tests Sales Channels

11.4.2 Rapid Prostate Cancer Tests Distributors

11.5 Rapid Prostate Cancer Tests Customers

12 Research Findings and Conclusion

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Rapid Prostate Cancer Tests CAGR in Value, United States VS Global, 2019 VS 2023 VS 2030

Table 2. Rapid Prostate Cancer Tests Market Trends

Table 3. Rapid Prostate Cancer Tests Market Drivers

Table 4. Rapid Prostate Cancer Tests Market Challenges

Table 5. Rapid Prostate Cancer Tests Market Restraints

Table 6. Global Rapid Prostate Cancer Tests Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. United States Rapid Prostate Cancer Tests Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global Rapid Prostate Cancer Tests Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 9. United States Rapid Prostate Cancer Tests Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 10. Global Key Manufacturers of Rapid Prostate Cancer Tests, Ranked by Revenue (2023) & (US$ Million)

Table 11. Global Rapid Prostate Cancer Tests Revenue by Manufacturer, (US$ Million) & (2019-2024)

Table 12. Global Rapid Prostate Cancer Tests Revenue Share by Manufacturer, 2019-2024

Table 13. Global Rapid Prostate Cancer Tests Sales by Manufacturer, (K Units), 2019-2024

Table 14. Global Rapid Prostate Cancer Tests Sales Share by Manufacturer, 2019-2024

Table 15. Global Rapid Prostate Cancer Tests Price by Manufacturer (2019-2024) & (US$/Unit)

Table 16. Global Rapid Prostate Cancer Tests Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Global Rapid Prostate Cancer Tests by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Prostate Cancer Tests as of 2023)

Table 18. Global Key Manufacturers of Rapid Prostate Cancer Tests, Manufacturing Base Distribution and Headquarters

Table 19. Global Key Manufacturers of Rapid Prostate Cancer Tests, Product Offered and Application

Table 20. Global Key Manufacturers of Rapid Prostate Cancer Tests, Date of Enter into This Industry

Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 22. Key Players of Rapid Prostate Cancer Tests in United States, Ranked by Revenue (2023) & (US$ million)

Table 23. United States Rapid Prostate Cancer Tests Revenue by Players, (US$ Million) & (2019-2024)

Table 24. United States Rapid Prostate Cancer Tests Revenue Share by Players, (2019-2024)

Table 25. United States Rapid Prostate Cancer Tests Sales by Players, (K Units) & (2019-2024)

Table 26. United States Rapid Prostate Cancer Tests Sales Share by Players, (2019-2024)

Table 27. Global Rapid Prostate Cancer Tests Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 28. Global Rapid Prostate Cancer Tests Sales in Volume by Region (2019-2024) & (K Units)

Table 29. Global Rapid Prostate Cancer Tests Sales in Volume Forecast by Region (2025-2030) & (K Units)

Table 30. Global Rapid Prostate Cancer Tests Sales in Value by Region (2019-2024) & (US$ Million)

Table 31. Global Rapid Prostate Cancer Tests Sales in Value Forecast by Region (2025-2030) & (US$ Million)

Table 32. Americas Rapid Prostate Cancer Tests Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. Americas Rapid Prostate Cancer Tests Sales in Value by Country (2019-2024) & (US$ Million)

Table 34. Americas Rapid Prostate Cancer Tests Sales in Value by Country (2025-2030) & (US$ Million)

Table 35. Americas Rapid Prostate Cancer Tests Sales in Volume by Country (2019-2024) & (K Units)

Table 36. Americas Rapid Prostate Cancer Tests Sales in Volume by Country (2025-2030) & (K Units)

Table 37. EMEA Rapid Prostate Cancer Tests Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. EMEA Rapid Prostate Cancer Tests Sales in Value by Country (2019-2024) & (US$ Million)

Table 39. EMEA Rapid Prostate Cancer Tests Sales in Value by Country (2025-2030) & (US$ Million)

Table 40. EMEA Rapid Prostate Cancer Tests Sales in Volume by Country (2019-2024) & (K Units)

Table 41. EMEA Rapid Prostate Cancer Tests Sales in Volume by Country (2025-2030) & (K Units)

Table 42. APAC Rapid Prostate Cancer Tests Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. APAC Rapid Prostate Cancer Tests Sales in Value by Country (2019-2024) & (US$ Million)

Table 44. APAC Rapid Prostate Cancer Tests Sales in Value by Country (2025-2030) & (US$ Million)

Table 45. APAC Rapid Prostate Cancer Tests Sales in Volume by Country (2019-2024) & (K Units)

Table 46. APAC Rapid Prostate Cancer Tests Sales in Volume by Country (2025-2030) & (K Units)

Table 47. Alfa Scientific Designs Company Information

Table 48. Alfa Scientific Designs Description and Business Overview

Table 49. Alfa Scientific Designs Rapid Prostate Cancer Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 50. Alfa Scientific Designs Rapid Prostate Cancer Tests Product

Table 51. Alfa Scientific Designs Recent Development

Table 52. BIOMERICA Company Information

Table 53. BIOMERICA Description and Business Overview

Table 54. BIOMERICA Rapid Prostate Cancer Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 55. BIOMERICA Rapid Prostate Cancer Tests Product

Table 56. BIOMERICA Recent Development

Table 57. Boson Biotech Company Information

Table 58. Boson Biotech Description and Business Overview

Table 59. Boson Biotech Rapid Prostate Cancer Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Boson Biotech Rapid Prostate Cancer Tests Product

Table 61. Boson Biotech Recent Development

Table 62. MH medical Company Information

Table 63. MH medical Description and Business Overview

Table 64. MH medical Rapid Prostate Cancer Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. MH medical Rapid Prostate Cancer Tests Product

Table 66. MH medical Recent Development

Table 67. NanoEntek Company Information

Table 68. NanoEntek Description and Business Overview

Table 69. NanoEntek Rapid Prostate Cancer Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. NanoEntek Rapid Prostate Cancer Tests Product

Table 71. NanoEntek Recent Development

Table 72. PRIMA Lab Company Information

Table 73. PRIMA Lab Description and Business Overview

Table 74. PRIMA Lab Rapid Prostate Cancer Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. PRIMA Lab Rapid Prostate Cancer Tests Product

Table 76. PRIMA Lab Recent Development

Table 77. Shenzhen kangshengbao Biotechnology Company Information

Table 78. Shenzhen kangshengbao Biotechnology Description and Business Overview

Table 79. Shenzhen kangshengbao Biotechnology Rapid Prostate Cancer Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Shenzhen kangshengbao Biotechnology Rapid Prostate Cancer Tests Product

Table 81. Shenzhen kangshengbao Biotechnology Recent Development

Table 82. Teco Diagnostics Company Information

Table 83. Teco Diagnostics Description and Business Overview

Table 84. Teco Diagnostics Rapid Prostate Cancer Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Teco Diagnostics Rapid Prostate Cancer Tests Product

Table 86. Teco Diagnostics Recent Development

Table 87. Key Raw Materials Lists

Table 88. Raw Materials Key Suppliers Lists

Table 89. Rapid Prostate Cancer Tests Distributors List

Table 90. Rapid Prostate Cancer Tests Customers List

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

List of Figures

Figure 1. Rapid Prostate Cancer Tests Product Picture

Figure 2. Global Rapid Prostate Cancer Tests Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 3. Global Rapid Prostate Cancer Tests Market Size 2019-2030 (US$ Million)

Figure 4. Global Rapid Prostate Cancer Tests Sales 2019-2030 (K Units)

Figure 5. United States Rapid Prostate Cancer Tests Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 6. United States Rapid Prostate Cancer Tests Market Size 2019-2030 (US$ Million)

Figure 7. United States Rapid Prostate Cancer Tests Sales 2019-2030 (K Units)

Figure 8. United States Rapid Prostate Cancer Tests Market Share in Global, in Value (US$ Million) 2019-2030

Figure 9. United States Rapid Prostate Cancer Tests Market Share in Global, in Volume (K Units) 2019-2030

Figure 10. Rapid Prostate Cancer Tests Report Years Considered

Figure 11. Product Picture of Serum

Figure 12. Product Picture of Whole Blood

Figure 13. Product Picture of Other

Figure 14. Global Rapid Prostate Cancer Tests Market Share by Type in 2023 & 2030

Figure 15. Global Rapid Prostate Cancer Tests Sales in Value by Type (2019-2030) & (US$ Million)

Figure 16. Global Rapid Prostate Cancer Tests Sales Market Share in Value by Type (2019-2030)

Figure 17. Global Rapid Prostate Cancer Tests Sales by Type (2019-2030) & (K Units)

Figure 18. Global Rapid Prostate Cancer Tests Sales Market Share in Volume by Type (2019-2030)

Figure 19. Global Rapid Prostate Cancer Tests Price by Type (2019-2030) & (US$/Unit)

Figure 20. United States Rapid Prostate Cancer Tests Market Share by Type in 2023 & 2030

Figure 21. United States Rapid Prostate Cancer Tests Sales in Value by Type (2019-2030) & (US$ Million)

Figure 22. United States Rapid Prostate Cancer Tests Sales Market Share in Value by Type (2019-2030)

Figure 23. United States Rapid Prostate Cancer Tests Sales by Type (2019-2030) & (K Units)

Figure 24. United States Rapid Prostate Cancer Tests Sales Market Share in Volume by Type (2019-2030)

Figure 25. United States Rapid Prostate Cancer Tests Price by Type (2019-2030) & (US$/Unit)

Figure 26. Product Picture of Hospital

Figure 27. Product Picture of Laboratory

Figure 28. Global Rapid Prostate Cancer Tests Market Share by Application in 2023 & 2030

Figure 29. Global Rapid Prostate Cancer Tests Sales in Value by Application (2019-2030) & (US$ Million)

Figure 30. Global Rapid Prostate Cancer Tests Sales Market Share in Value by Application (2019-2030)

Figure 31. Global Rapid Prostate Cancer Tests Sales by Application (2019-2030) & (K Units)

Figure 32. Global Rapid Prostate Cancer Tests Sales Market Share in Volume by Application (2019-2030)

Figure 33. Global Rapid Prostate Cancer Tests Price by Application (2019-2030) & (US$/Unit)

Figure 34. United States Rapid Prostate Cancer Tests Market Share by Application in 2023 & 2030

Figure 35. United States Rapid Prostate Cancer Tests Sales in Value by Application (2019-2030) & (US$ Million)

Figure 36. United States Rapid Prostate Cancer Tests Sales Market Share in Value by Application (2019-2030)

Figure 37. United States Rapid Prostate Cancer Tests Sales by Application (2019-2030) & (K Units)

Figure 38. United States Rapid Prostate Cancer Tests Sales Market Share in Volume by Application (2019-2030)

Figure 39. United States Rapid Prostate Cancer Tests Price by Application (2019-2030) & (US$/Unit)

Figure 40. The Top 5 and 10 Largest Manufacturers of Rapid Prostate Cancer Tests in the World: Market Share by Rapid Prostate Cancer Tests Revenue in 2023

Figure 41. Global Rapid Prostate Cancer Tests Market Size Market Share by Region: 2019 VS 2023 VS 2030

Figure 42. Global Rapid Prostate Cancer Tests Sales in Volume Market Share by Region (2019-2030)

Figure 43. Global Rapid Prostate Cancer Tests Sales in Value Market Share by Region (2019-2030)

Figure 44. Americas Rapid Prostate Cancer Tests Sales in Volume Growth Rate 2019-2030 (K Units)

Figure 45. Americas Rapid Prostate Cancer Tests Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 46. Americas Rapid Prostate Cancer Tests Sales by Type (2019-2030) & (K Units)

Figure 47. Americas Rapid Prostate Cancer Tests Sales Market Share in Volume by Type (2019-2030)

Figure 48. Americas Rapid Prostate Cancer Tests Sales by Application (2019-2030) & (K Units)

Figure 49. Americas Rapid Prostate Cancer Tests Sales Market Share in Volume by Application (2019-2030)

Figure 50. United States Rapid Prostate Cancer Tests Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 51. Canada Rapid Prostate Cancer Tests Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 52. Mexico Rapid Prostate Cancer Tests Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 53. Brazil Rapid Prostate Cancer Tests Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 54. EMEA Rapid Prostate Cancer Tests Sales in Volume Growth Rate 2019-2030 (K Units)

Figure 55. EMEA Rapid Prostate Cancer Tests Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 56. EMEA Rapid Prostate Cancer Tests Sales by Type (2019-2030) & (K Units)

Figure 57. EMEA Rapid Prostate Cancer Tests Sales Market Share in Volume by Type (2019-2030)

Figure 58. EMEA Rapid Prostate Cancer Tests Sales by Application (2019-2030) & (K Units)

Figure 59. EMEA Rapid Prostate Cancer Tests Sales Market Share in Volume by Application (2019-2030)

Figure 60. Europe Rapid Prostate Cancer Tests Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 61. Middle East Rapid Prostate Cancer Tests Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 62. Africa Rapid Prostate Cancer Tests Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 63. China Rapid Prostate Cancer Tests Sales in Volume Growth Rate 2019-2030 (K Units)

Figure 64. China Rapid Prostate Cancer Tests Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 65. China Rapid Prostate Cancer Tests Sales by Type (2019-2030) & (K Units)

Figure 66. China Rapid Prostate Cancer Tests Sales Market Share in Volume by Type (2019-2030)

Figure 67. China Rapid Prostate Cancer Tests Sales by Application (2019-2030) & (K Units)

Figure 68. China Rapid Prostate Cancer Tests Sales Market Share in Volume by Application (2019-2030)

Figure 69. APAC Rapid Prostate Cancer Tests Sales in Volume Growth Rate 2019-2030 (K Units)

Figure 70. APAC Rapid Prostate Cancer Tests Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 71. APAC Rapid Prostate Cancer Tests Sales by Type (2019-2030) & (K Units)

Figure 72. APAC Rapid Prostate Cancer Tests Sales Market Share in Volume by Type (2019-2030)

Figure 73. APAC Rapid Prostate Cancer Tests Sales by Application (2019-2030) & (K Units)

Figure 74. APAC Rapid Prostate Cancer Tests Sales Market Share in Volume by Application (2019-2030)

Figure 75. Japan Rapid Prostate Cancer Tests Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 76. South Korea Rapid Prostate Cancer Tests Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 77. China Taiwan Rapid Prostate Cancer Tests Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 78. Southeast Asia Rapid Prostate Cancer Tests Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 79. India Rapid Prostate Cancer Tests Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 80. Rapid Prostate Cancer Tests Value Chain

Figure 81. Rapid Prostate Cancer Tests Production Process

Figure 82. Channels of Distribution (Direct Vs Distribution)

Figure 83. Bottom-up and Top-down Approaches for This Report

Figure 84. Data Triangulation

Figure 85. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Rapid Prostate Cancer Tests in 2024? zhanKai

The global market size of Rapid Prostate Cancer Tests in 2024 was 77 Million USD.

Which companies rank high in the global Rapid Prostate Cancer Tests market? shouQi

What was the global market size of Rapid Prostate Cancer Tests in 2030? shouQi

What is the annual compound growth rate of the global Rapid Prostate Cancer Tests market size from 2024 to 2030? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Global Rapid Prostate Cancer Tests Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Rapid Prostate Cancer Tests market is projected to grow from US$ 79.98 million in 2025 to US$ 107 million by 2032, at a CAGR of 4.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-25
Pages: 139
USD 4900.00
(Single User License)
Global Rapid Prostate Cancer Tests Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Rapid Prostate Cancer Tests market size was US$ 79.98 million in 2025 and is forecast to reach a readjusted size of US$ 107 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 80
USD 4250.00
(Single User License)
Global Rapid Prostate Cancer Tests Market Research Report 2026
The global Rapid Prostate Cancer Tests market was valued at US$ 79.98 million in 2025 and is anticipated to reach US$ 107 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 111
USD 2900.00
(Single User License)
Rapid Prostate Cancer Tests- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Rapid Prostate Cancer Tests was estimated to be worth US$ 79.98 million in 2025 and is projected to reach US$ 107 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 91
USD 3950.00
(Single User License)
Global Rapid Prostate Cancer Tests Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Rapid Prostate Cancer Tests market size was US$ 77 million in 2024 and is forecast to a readjusted size of US$ 103 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 79
USD 4250.00
(Single User License)
Global Rapid Prostate Cancer Tests Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Rapid Prostate Cancer Tests market is projected to grow from US$ 77 million in 2024 to US$ 103 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-01
Pages: 143
USD 4900.00
(Single User License)
Rapid Prostate Cancer Tests - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Rapid Prostate Cancer Tests was estimated to be worth US$ 77 million in 2024 and is forecast to a readjusted size of US$ 103 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 97
USD 3950.00
(Single User License)
Global Rapid Prostate Cancer Tests Market Research Report 2025
The global market for Rapid Prostate Cancer Tests was valued at US$ 77 million in the year 2024 and is projected to reach a revised size of US$ 103 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published Date: 2025-03-10
Pages: 84
USD 2900.00
(Single User License)
Global Rapid Prostate Cancer Tests Market Insights, Forecast to 2030
Valued at US$ 77 million in 2024, the global Rapid Prostate Cancer Tests market is forecast to reach US$ 99 million by 2030, at a CAGR of 4.3% during the forecast period.
Published Date: 2024-11-26
Pages: 138
USD 4900.00
(Single User License)
Rapid Prostate Cancer Tests- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Rapid Prostate Cancer Tests was estimated to be worth US$ 73 million in 2023 and is forecast to a readjusted size of US$ 99 million by 2030 with a CAGR of 4.3% during the forecast period 2024-2030.
Published Date: 2024-11-26
Pages: 99
USD 3950.00
(Single User License)

Global Rapid Prostate Cancer Tests Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Rapid Prostate Cancer Tests market is projected to grow from US$ 79.98 million in 2025 to US$ 107 million by 2032, at a CAGR of 4.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-25
Pages: 139
USD 4900.00 (Single User License)
Global Rapid Prostate Cancer Tests Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Rapid Prostate Cancer Tests market size was US$ 79.98 million in 2025 and is forecast to reach a readjusted size of US$ 107 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 80
USD 4250.00 (Single User License)
Global Rapid Prostate Cancer Tests Market Research Report 2026
The global Rapid Prostate Cancer Tests market was valued at US$ 79.98 million in 2025 and is anticipated to reach US$ 107 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-01-08
Pages: 111
USD 2900.00 (Single User License)
Rapid Prostate Cancer Tests- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Rapid Prostate Cancer Tests was estimated to be worth US$ 79.98 million in 2025 and is projected to reach US$ 107 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-01-08
Pages: 91
USD 3950.00 (Single User License)
Global Rapid Prostate Cancer Tests Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Rapid Prostate Cancer Tests market size was US$ 77 million in 2024 and is forecast to a readjusted size of US$ 103 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 79
USD 4250.00 (Single User License)
Global Rapid Prostate Cancer Tests Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Rapid Prostate Cancer Tests market is projected to grow from US$ 77 million in 2024 to US$ 103 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-01
Pages: 143
USD 4900.00 (Single User License)
Rapid Prostate Cancer Tests - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Rapid Prostate Cancer Tests was estimated to be worth US$ 77 million in 2024 and is forecast to a readjusted size of US$ 103 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 97
USD 3950.00 (Single User License)
Global Rapid Prostate Cancer Tests Market Research Report 2025
The global market for Rapid Prostate Cancer Tests was valued at US$ 77 million in the year 2024 and is projected to reach a revised size of US$ 103 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published: 2025-03-10
Pages: 84
USD 2900.00 (Single User License)
Global Rapid Prostate Cancer Tests Market Insights, Forecast to 2030
Valued at US$ 77 million in 2024, the global Rapid Prostate Cancer Tests market is forecast to reach US$ 99 million by 2030, at a CAGR of 4.3% during the forecast period.
Published: 2024-11-26
Pages: 138
USD 4900.00 (Single User License)
Rapid Prostate Cancer Tests- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Rapid Prostate Cancer Tests was estimated to be worth US$ 73 million in 2023 and is forecast to a readjusted size of US$ 99 million by 2030 with a CAGR of 4.3% during the forecast period 2024-2030.
Published: 2024-11-26
Pages: 99
USD 3950.00 (Single User License)